期刊文献+

急性缺血性卒中患者凝血、抗凝活性和血液流变学变化规律的研究 被引量:1

Changes of Blood Coagulation, Anti-Coagulation Activity and Hemorheology after Acute Cerebral Infarction
下载PDF
导出
摘要 目的研究急性缺血性卒中患者凝血活性、抗凝活性和血液流变学的变化规律。方法选择40例急性缺血性卒中患者和30例健康体检者,采集静脉血,用血凝仪检测血浆纤维蛋白原(Fibrinogen,Fib)、抗凝血酶川活性(Antithrombin Ⅲ:α,AT—Ⅲ:α),用自动血流变测试仪检测血液流变学的指标。对比两组上述指标的差异。结果缺血性卒中后急性期Fib(4.3±1.6g/L)高于对照组(2.9±1.4g/L),有统计学差异(P<0.01),全血和血浆粘度、红细胞压积、红细胞沉降率高于对照组,均有统计学差异(P<0.05),AT—Ⅲ:α在急性期明显低于对照组,有统计学差异(P<0.01)。结论缺血性卒中急性期Fib升高,血液黏度增加,凝血活性增强及抗凝血活性降低。 Objective To study the changes of blood coagulation activity, anti-coagulation activity and hemorheology in patients with acute cerebral infarction. Methods Venous blood samples were collected from 40 patients with acute cerebral infarction and 30 healthy individuals, to examine the levels of Fib, AT-Ⅲ:α with blood coagulation analyzer and hemorheology indexes with automatic hemorheology instrument and to compare the differences between the two groups. Results Fibrinogen(Fib) of the acute cerebral infarction group(4.3±1.6g/L) are higher than that of the control group(2.9±1.4g/L), which has significant difference(P〈0.01). The whole blood viscosity, plasma viscosity, hematocrit (HCT) and erythrocyte sedimentation rate (ESR) of the acute cerebral infarction group are higher than those of the control group,which has significant difference (P〈0.05), AT-Ⅲ:α decreases obviously at acute stage of cerebral infarction, which has significant difference also(P〈0.01). Conclusion After acute cerebral infarction, Fib and blood viscosity increase, blood coagulant activity increases and anticoagulant activity decreases.
出处 《中国卒中杂志》 2010年第8期616-618,共3页 Chinese Journal of Stroke
关键词 脑梗死 纤维蛋白原 抗凝血酶Ⅲ 血液流变学 Cerebral infarction Fibrinogen Antithrombin III Hemorheology
  • 相关文献

参考文献6

二级参考文献36

  • 1急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 2李学洲,蔡大立,主编.内科治疗学.北京:人民卫生出版社,1984.216.
  • 3Arbustini E, De Servi S, Bramucci E, et al. Comparison of coronary Lesions obtained bydirectional Coronary atherectomy in unstable angina,stableangina,and vestenosis after either athereetomg or angionlasty Am J Cardiol, 1995,75:675 - 682.
  • 4Ernst E.Resch KL.Fibrinogen as a cardiovascular risk factor:a meta-analysis and review of the literature[J].Ann Int Med.1993.118:956-963.
  • 5Baumann H.Gauldie J.The acute plase response[J].Immunol Today, 1994,15:74-80.
  • 6Behagus I.Poirier O,Nicard V.et al β-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction.The ECTIM study[J].Circulation 1996,88:3698-3704.
  • 7Roy S.LVerton O.Redman C.Overexpression of any fibrinogen chain by Hpe G2 cells specifically elvates the expression of the other two chains[J].J Biol Chem.1994.269:691-695.
  • 8Brown ET.Fuller GM.Detection of a comlex that associated with the Bβ-fibrinogen G445A polymophism[J]. Blood, 1998,92,3286-3293.
  • 9Balleisen L.Assmann JB.Epping PH.et al.Epidemiological study on factor Ⅶ factor Ⅷ and fibrinogen in an inducstrial population -Ⅱ Thromb Heamost 1985,54:721-723.
  • 10Fiendlander Y.Elkans Y.Sirmreigh R.et al.Genetic and enviormental sources of fibrinogen variability in israeli families:the Kibbutzim Family Study[J].Am J Hum Genet 1995,56: 1194-1206.

共引文献15769

同被引文献7

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部